Mastodawn

Gage Moreno Aug 18, 2023

Aug 18, 2023

Finally, if you have a #SARSCoV2 sequencing pipeline that uses the #Nextclade CLI, please *pull the latest update*, as it includes BA.2.86 & will help you quickly ID sequences.
This is also updated online if you scan sequences there!
http://clades.nextstrain.org

9/9

Nextclade

Genetic sequence alignment, clade assignment, mutation calling, phylogenetic placement, and quality checks for SARS-CoV-2, Influenza (Flu), Monkeypox, Respiratory Syncytial Virus (RSV) and other pathogens

Gage Moreno May 3, 2023

RT @HelenBranswell
It's taken decades, but there is finally a vaccine to protect against serious disease from #RSV. This one's for adults 60 and older, from #GSK. Options for protecting infants coming later this year. https://www.statnews.com/2023/05/03/fda-approves-rsv-vaccine-gsk/

FDA approves first RSV vaccine, a long-sought scientific achievement

The FDA has approved the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making.

STAT

Gage Moreno May 3, 2023

COVID entering its wavelet era
---
RT @TWenseleers
"COVID's future: mini-waves rather than seasonal surges", by @ewencallaway, with some input from me and @trvrb, among others. https://www.nature.com/articles/d41586-023-01437-8
https://twitter.com/TWenseleers/status/1653502243520368646

COVID's future: mini-waves rather than seasonal surges

Three years after the start of the pandemic, SARS-CoV-2 shows no signs of settling into a seasonal pattern of spread, like influenza has.

Gage Moreno Apr 28, 2023

RT @JustinLessler
Finally out, our paper on sample size calculation for variant surveillance in @CellRepMed , with the amazing @shirleewohl @Ymax and @bethanydiprete .

https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(23)00132-5

Gage Moreno Apr 27, 2023

RT @NathanGrubaugh
📢 Job announcement - pls RT

We are seeking a Postdoc with a background in pathogen genomics (primarily wet-lab) to develop and implement sequencing strategies for surveillance and outbreak response. 🦠🧫🧬

See here for details 👉
https://grubaughlab.com/postdoc-in-pathogen-genomic-applications-for-public-health/

Postdoc in pathogen genomic applications for public health | Grubaugh Lab

The Grubaugh Lab at the Yale School of Public Health (YSPH) is seeking a Postdoctoral Associate with a background in pathogen genomics (primarily wet-lab) to develop and implement sequencing strategies for surveillance and outbreak response, as a part of the Pathogen Genomic Center of Excellence (PGCOE). The Massachusetts Department of Public Health (MDPH) selected the… Read more

Grubaugh Lab

Gage Moreno Apr 20, 2023

RT @cjriIllingworth
New preprint out from my group at @CVRinfo. https://biorxiv.org/cgi/content/short/2023.04.14.536864v1. Previously we and others have used genomic data to look at how many viruses found new infections with flu or SARS-CoV-2. Here we took a different approach. 1/12

Gage Moreno Apr 20, 2023

RT @firefoxx66
A Q I've seen: "How did this stay quiet so long?"

Quote from the article:
"Many sources who spoke to Science declined to be named out of fear of legal action from Bogner or of losing GISAID access."

Scientists depend on GISAID access. Fear is powerful.

https://www.science.org/content/article/invented-persona-behind-key-pandemic-database

The ‘invented persona’ behind a key pandemic database

GISAID offers a safe space to post viral genomes. Peter Bogner, its perplexing creator and overseer, may be jeopardizing its future

Gage Moreno Apr 18, 2023

RT @US_FDA
Today, FDA amended the EUAs of the Pfizer-BioNTech and Moderna COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines
What you need to know. 🧵👇

Coronavirus (COVID-19) Update: FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines

The FDA amended the EUAs of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.

U.S. Food and Drug Administration

Gage Moreno Apr 13, 2023

RT @leslievosshall
🧵📢
We need to retain talented postdocs in academic science. I'm happy to say that @HHMINEWS has taken a big step forward this week.
$70,000
That's the new starting minimum salary for all postdocs employed in HHMI labs
https://www.hhmi.org/sites/default/files/hhmi-postdoctoral-associate-scale.pdf (1/4) https://twitter.com/HHMINEWS/status/1646517344628523010

Gage Moreno Apr 11, 2023

RT @CecileTK_
I am really excited to share our new preprint https://tinyurl.com/zy4ueuxy on how we can use clusters of identical pathogen sequences to estimate the reproduction number R and the dispersion parameter k (that quantifies transmission heterogeneity)! with @trvrb

Twitter	https://twitter.com/GageKMoreno
Personal Website	https://www.gagemoreno.com